Literature DB >> 17701604

Acute promyelocytic leukemia in patients aged 70 years and over -- a single center experience of unselected patients.

Patricia Disperati, Mark D Minden, Vikas Gupta, Aaron D Schimmer, Andre C Schuh, Karen W L Yee, Suzanne Kamel-Reid, Hong Chang, Wei Xu, Joseph M Brandwein.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17701604     DOI： 10.1080/10428190701472005

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

Review 1.  Levels of care: defining best supportive care in elderly patients with acute myeloid leukemia.

Authors:  Ellen K Ritchie; Gail J Roboz
Journal:  Curr Hematol Malig Rep       Date:  2010-04       Impact factor: 3.952

2.  Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus.

Authors:  Joseph M Brandwein; Michelle Geddes; Jeannine Kassis; Andrea K Kew; Brian Leber; Thomas Nevill; Mitchell Sabloff; Irwindeep Sandhu; Andre C Schuh; John M Storring; John Ashkenas
Journal:  Am J Blood Res       Date:  2013-05-05

3.  FLT3 in lineage specification and plasticity.

Authors:  Sarah Greenblatt; Donald Small
Journal:  Oncotarget       Date:  2012-05

Review 4.  Management of elderly patients with acute promyelocytic leukemia: progress and problems.

Authors:  Eva Lengfelder; Wolf-Karsten Hofmann; Florian Nolte
Journal:  Ann Hematol       Date:  2013-05-22       Impact factor: 3.673

5.  Management of acute promyelocytic leukemia in the elderly.

Authors:  Francesco Lo-Coco; Roberto Latagliata; Massimo Breccia
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-06-08       Impact factor: 2.576

6.  Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.

Authors:  Lionel Adès; Pau Montesinos; Sabine Kayser; Ramy Rahmé; David Martínez-Cuadrón; Gabriel Ghiaur; Xavier Thomas; Marta Sobas; Agnes Guerci-Bresler; Ana Garrido; Arnaud Pigneux; Cristina Gil; Emmanuel Raffoux; Mar Tormo; Norbert Vey; Javier de la Serna; Olga Salamero; Eva Lengfelder; Mark J Levis; Pierre Fenaux; Miguel A Sanz; Uwe Platzbecker; Richard F Schlenk
Journal:  Leukemia       Date:  2020-02-19       Impact factor: 11.528
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.